-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Equal-Weight on Axsome Therapeutics, Raises Price Target to $242

Benzinga·05/05/2026 15:34:09
Listen to the news
Morgan Stanley analyst Sean Laaman maintains Axsome Therapeutics (NASDAQ:AXSM) with a Equal-Weight and raises the price target from $217 to $242.